ECM
ABBV icon

Endex Capital Management’s AbbVie ABBV Stock Holding History

Endex Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$813K Hold
15,393
– – 0.76% 32
2013
Q3 		$689K Hold
15,393
– – 0.71% 35
2013
Q2 		$636K Buy
+15,393
New +$673K 0.68% 41

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Endex Capital Management's ABBV Position: Q4 2013 in Review

Endex Capital Management held its AbbVie (ABBV) position steady in Q4 2013 at 15,393 shares worth $813K. The position accounts for 0.76% of the portfolio, ranked #32.

Endex Capital Management first reported a position in ABBV in Q2 2013 and has held it in 3 quarters since. 1,435 funds tracked by Wall St. Rank hold ABBV as of Q4 2013.

  • Endex Capital Management held 15,393 shares of AbbVie worth $813K as of Q4 2013.
  • Endex Capital Management left its AbbVie share count unchanged in Q4 2013.
  • AbbVie made up 0.76% of Endex Capital Management's portfolio in Q4 2013, its #32 holding.
  • Endex Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 3 quarters since.
  • 1,435 funds tracked by Wall St. Rank held AbbVie as of Q4 2013.

Based on Endex Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.